Home » References » Byondis Nijmegen, mAb Plant

Byondis Nijmegen, mAb Plant

Detail engineering and installation of a Monoclonal Antibody (mAb) Plant, in collaboration with Heijmans.
In the mAb plant, therapeutic protein molecules are produced for use in cancer drugs.